Works matching Methotrexate (drug interactions)

Results: 56

Pharmacokinetic drug--drug interactions with methotrexate in oncology.

Published in:

Expert Review of Clinical Pharmacology, 2011, v. 4, n. 6, p. 743

By:

Levêque, Dominique;
Santucci, Raoul;
Gourieux, Bénédicte;
Herbrecht, Raoul

Publication type:

Article

Accumulating Evidence for a Drug-Interaction Between Methotrexate and Proton Pump Inhibitors.

Published in:

Oncologist, 2012, v. 17, n. 4, p. 550, doi. 10.1634/theoncologist.2011-0431

By:

BEZABEH, SHEWIT;
CORKEN MACKEY, ANN;
KLUETZ, PAUL;
JAPPAR, DILARA;
KORVICK, JOYCE

Publication type:

Article

Interaction of Anticancer Drug Methotrexate with DS-DNA Analyzed by Spectroscopic and Electrochemical Methods.

Published in:

E-Journal of Chemistry, 2012, v. 9, n. 1, p. 471, doi. 10.1155/2012/378674

By:

Hajian, R.;
Tavakol, M.

Publication type:

Article

Suspicion of Drug-Drug Interaction between High-Dose Methotrexate and Proton Pump Inhibitors: A Case Report - Should the Practice Be Changed?

Published in:

Chemotherapy (0009-3157), 2011, v. 57, n. 3, p. 225, doi. 10.1159/000327372

By:

Ranchon;
Vantard;
Gouraud;
Schwiertz;
Franchon;
Pham;
Vial;
You;
Bouafia;
Salles;
Rioufol

Publication type:

Article

An acute herb--drug interaction of Magnoliae Officinalis Cortex with methotrexate via inhibiting multidrug resistance-associated protein 2.

Published in:

Journal of Food & Drug Analysis, 2024, v. 32, n. 1, p. 103, doi. 10.38212/2224-6614.3495

By:

Chung-Ping Yu;
Pei-Ying Li;
Szu-Yu Chen;
Shiuan-Pey Lin;
Ying-Chen Chen;
Lu-Ching Ho;
Yow-Wen Hsieh;
Yu-Chi Hou

Publication type:

Article

Practical Clinical Pharmacology and Drug Interactions of Low-Dose Methotrexate Therapy in Rheumatoid Arthritis.

Published in:

British Journal of Rheumatology, 1995, v. XXXIV, n. suppl_4, p. 20, doi. 10.1093/rheumatology/XXXIV.suppl_2.20

By:

Furst, D. E.

Publication type:

Article

Practical Clinical Pharmacology and Drug Interactions of Low-Dose Methotrexate Therapy in Rheumatoid Arthritis.

Published in:

British Journal of Rheumatology, 1995, v. XXXIV, n. suppl_2, p. 20, doi. 10.1093/rheumatology/XXXIV.suppl_2.20

By:

Furst, D. E.

Publication type:

Article

Weak Interaction of the Antimetabolite Drug Methotrexate with a Cavitand Derivative.

Published in:

International Journal of Molecular Sciences, 2020, v. 21, n. 12, p. 4345, doi. 10.3390/ijms21124345

By:

Preisz, Zsolt;
Nagymihály, Zoltán;
Lemli, Beáta;
Kollár, László;
Kunsági-Máté, Sándor

Publication type:

Article

The key role of organic anion transporter 3 in the drug–drug interaction between tranilast and methotrexate.

Published in:

Journal of Biochemical & Molecular Toxicology, 2022, v. 36, n. 4, p. 1, doi. 10.1002/jbt.22983

By:

Wang, Jingjing;
Yuan, Wenjing;
Shen, Qingqing;
Wu, Qipeng;
Jiang, Zhenzhou;
Wu, Wei;
Zhang, Luyong;
Huang, Xin

Publication type:

Article

Investigation of the Mechanism of Therapeutic Protein-Drug Interaction Between Methotrexate and Golimumab, an Anti-TNFα Monoclonal Antibody.

Published in:

AAPS Journal, 2018, v. 20, n. 3, p. 1, doi. 10.1208/s12248-018-0219-4

By:

Wang, Weirong;
Leu, Jocelyn;
Watson, Rebecca;
Xu, Zhenhua;
Zhou, Honghui

Publication type:

Article

Delayed methotrexate elimination: Incidence, interaction with antacid drugs, and clinical consequences?

Published in:

2018

By:

Ranchon, Florence;
Vantard, Nicolas;
Henin, Emilie;
Bachy, Emmanuel;
Sarkozy, Clémentine;
Karlin, Lionel;
Bouafia‐Sauvy, Fadhela;
Gouraud, Aurore;
Schwiertz, Verane;
Bourbon, Estelle;
Baudouin, Amandine;
Caffin, Anne Gaelle;
Vial, Thierry;
Salles, Gilles;
Rioufol, Catherine;
Bouafia-Sauvy, Fadhela

Publication type:

journal article

Lack of drug interaction between levetiracetam and high‐dose methotrexate in patients with lymphoma.

Published in:

Pharmacotherapy, 2021, v. 41, n. 5, p. 430, doi. 10.1002/phar.2516

By:

DeFino, Catherine E.;
Barreto, Jason N.;
Pawlenty, Amanda G.;
Ruff, Michael W.;
Carabenciov, Ivan D.;
Mara, Kristin C.;
Thompson, Carrie A.

Publication type:

Article

Pralatrexate Monitoring Using a Commercially Available Methotrexate Assay to Avoid Potential Drug Interactions.

Published in:

Pharmacotherapy, 2016, v. 36, n. 2, p. e8, doi. 10.1002/phar.1699

By:

McPherson, Jordan P.;
Vrontikis, Alaina;
Sedillo, Courtney;
Halwani, Ahmad S.;
Gilreath, Jeffrey A.

Publication type:

Article

Reply: Methotrexate neurotoxicity due to drug interactions: an inadequate folinic acid effect.

Published in:

2017

By:

Forster, Victoria;
Delft, Frederik;
Baird, Susan;
Mair, Shona;
Skinner, Roderick;
Halsey, Christina;
Forster, Victoria J;
van Delft, Frederik W;
Baird, Susan F

Publication type:

Letter

Methotrexate neurotoxicity due to drug interactions: an inadequate folinic acid effect?

Published in:

2017

By:

Cohen, Ian;
Cohen, Ian Joseph

Publication type:

Letter

MDR1 and OAT1/OAT3 Mediate the Drug-Drug Interaction between Puerarin and Methotrexate.

Published in:

Pharmaceutical Research, 2014, v. 31, n. 5, p. 1120, doi. 10.1007/s11095-013-1235-9

By:

Liu, Qi;
Wang, Changyuan;
Meng, Qiang;
Huo, Xiaokui;
Sun, Huijun;
Peng, Jinyong;
Ma, Xiaochi;
Sun, Pengyuan;
Liu, Kexin

Publication type:

Article

Drug-Drug Interaction Between Methotrexate and Levetiracetam Resulting in Delayed Methotrexate Elimination.

Published in:

Annals of Pharmacotherapy, 2014, v. 48, n. 2, p. 292, doi. 10.1177/1060028013511951

By:

Bain, Emily;
Birhiray, Ruemu E.;
Reeves, David J.

Publication type:

Article

Severe phototoxicity associated with concomitant use of methotrexate and voriconazole, an overlooked drug-drug interaction.

Published in:

2020

By:

Bogaert, Delfien J.;
Verlinden, Louisa;
Vandecruys, Els;
Laureys, Geneviève;
Verhaeghe, Evelien;
Bauters, Tiene

Publication type:

Case Study

Drug-drug interaction between methotrexate and levetiracetam in a child treated for acute lymphoblastic leukemia.

Published in:

Pediatric Blood & Cancer, 2013, v. 60, n. 2, p. 340, doi. 10.1002/pbc.24371

By:

Parentelli, Anne‐Sophie;
Phulpin‐Weibel, Aurélie;
Mansuy, Ludovic;
Contet, Audrey;
Trechot, Philippe;
Chastagner, Pascal

Publication type:

Article

Pancytopenia Due to Possible Drug–Drug Interactions Between Low-Dose Methotrexate and Proton Pump Inhibitors.

Published in:

Drug, Healthcare & Patient Safety, 2022, v. 14, p. 75, doi. 10.2147/DHPS.S350194

By:

Tao, Dan;
Wang, Hui;
Xia, Fangfang;
Ma, Wenlu

Publication type:

Article

A possible interaction between favipiravir and methotrexate: Drug-induced hepatotoxicity in a patient with osteosarcoma.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 445, doi. 10.1177/10781552211031304

By:

Demir, Emre;
Sütcüoğlu, Osman;
Demir, Beril;
Ünsal, Oktay;
Yazıcı, Ozan

Publication type:

Article

High-dose methotrexate in adult oncology patients: A case-control study assessing the risk association between drug interactions and methotrexate toxicity.

Published in:

Journal of Oncology Pharmacy Practice, 2014, v. 20, n. 2, p. 93, doi. 10.1177/1078155213482602

By:

Chan, April J;
Rajakumar, Irina

Publication type:

Article

Investigation of Potential Drug–Drug Interactions between Peficitinib (ASP015K) and Methotrexate in Patients with Rheumatoid Arthritis.

Published in:

Clinical Drug Investigation, 2020, v. 40, n. 9, p. 827, doi. 10.1007/s40261-020-00937-z

By:

Zhu, Tong;
Moy, Selina;
Valluri, Udaya;
Cao, Ying;
Zhang, Wenhui;
Sawamoto, Taiji;
Chindalore, Vishala;
Akinlade, Bola

Publication type:

Article

High Prevalence of Potential Drug-Drug Interactions for Psoriasis Patients Prescribed Methotrexate or Cyclosporine for Psoriasis: Associated Clinical and Economic Outcomes in Real-World Practice.

Published in:

Dermatology (10188665), 2010, v. 220, n. 2, p. 128, doi. 10.1159/000275198

By:

Saurat, Jean-Hilaire;
Guérin, Annie;
Yu, Andrew P.;
Latremouille-Viau, Dominick;
Wu, Eric Q.;
Gupta, Shiraz R.;
Bao, Yanjun;
Mulani, Parvez M.

Publication type:

Article

Effects of proton pump inhibitors and famotidine on elimination of plasma methotrexate: Evaluation of drug-drug interactions mediated by organic anion transporter 3.

Published in:

Biopharmaceutics & Drug Disposition, 2017, v. 38, n. 9, p. 501, doi. 10.1002/bdd.2091

By:

Narumi, Katsuya;
Sato, Yu;
Kobayashi, Masaki;
Furugen, Ayako;
Kasashi, Kumiko;
Yamada, Takehiro;
Teshima, Takanori;
Iseki, Ken

Publication type:

Article

Comprehensive Evaluation of OATP‐ and BCRP‐Mediated Drug–Drug Interactions of Methotrexate Using Physiologically‐Based Pharmacokinetic Modeling.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 4, p. 1013, doi. 10.1002/cpt.3329

By:

Hwang, Sejung;
Lee, Yujin;
Jang, Yeonseo;
Cho, Joo‐Youn;
Yoon, Seonghae;
Chung, Jae‐Yong

Publication type:

Article

Polypharmacy and potential drug–drug interactions in patients with rheumatoid arthritis.

Published in:

Medical Journal of Babylon, 2022, v. 19, n. 3, p. 396, doi. 10.4103/MJBL.MJBL_51_22

By:

Al-Ghazaly, Zakaria;
Jassim, Nizar

Publication type:

Article

Risk-Benefit Assessment of Methotrexate in the Treatment of Severe Psoriasis.

Published in:

American Journal of Clinical Dermatology, 2000, v. 1, n. 1, p. 27, doi. 10.2165/00128071-200001010-00003

By:

Kuijpers, A.L.;
van der Kerkhof, P.C.M.

Publication type:

Article

Important Drug Interactions in Dermatology.

Published in:

Drugs, 2000, v. 59, n. 2, p. 181, doi. 10.2165/00003495-200059020-00003

By:

Roos, T.C.;
Merk, H.F.

Publication type:

Article

Clinically Important Drug Interactions with Disease-Modifying Antirheumatic Drugs.

Published in:

Drugs & Aging, 1998, v. 13, n. 4, p. 281, doi. 10.2165/00002512-199813040-00004

By:

Haagsma, C.J.

Publication type:

Article

Lack of Drug Interaction Conformity in Commonly Used Drug Compendia for Selected At-Risk Dermatologic Drugs.

Published in:

American Journal of Clinical Dermatology, 2005, v. 6, n. 2, p. 105, doi. 10.2165/00128071-200506020-00005

By:

Chao, Stephanie D.;
Maibach, Howard I.

Publication type:

Article

Risk of Hematologic Events With Coadministration of Methotrexate and the Breast Cancer Resistance Protein Inhibitor Febuxostat.

Published in:

Annals of Pharmacotherapy, 2022, v. 56, n. 8, p. 910, doi. 10.1177/10600280211055794

By:

Mitsuboshi, Satoru;
Niimura, Takahiro;
Kanda, Masaya;
Ishida, Shunsuke;
Zamami, Yoshito;
Ishizawa, Keisuke

Publication type:

Article

Correspondence.

Published in:

1989

By:

Dewsbury, Catherine E.;
Graham, Pamela;
Darley, C. R.;
Liddle, B. J.;
Marsden, J. R.;
Stubb, Sakari;
Alanko, Kristiina;
Reitamo, Sakari;
Dunna, S. F.;
Finlay, A. Y.

Publication type:

Letter

Methotrexate Toxicity During Treatment of Chronic Plaque Psoriasis: A Case Report and Review of the Literature.

Published in:

Dermatology & Therapy, 2014, v. 4, n. 2, p. 145, doi. 10.1007/s13555-014-0056-z

By:

Weidmann, Anja;
Foulkes, Amy;
Kirkham, N.;
Reynolds, N.

Publication type:

Article

Should nitrous oxide ever be used in oncology patients receiving methotrexate therapy?

Published in:

Pediatric Anesthesia, 2020, v. 30, n. 1, p. 9, doi. 10.1111/pan.13760

By:

Forster, Victoria J.;
Bell, Graham;
Halsey, Christina;
Veyckemans, Francis

Publication type:

Article

Trimethoprim‐sulfamethoxazole as Pneumocystis jiroveci pneumonia prevention in patients undergoing methotrexate therapy for hematological malignancies: A review of the literature.

Published in:

Hematological Oncology, 2021, v. 39, n. 2, p. 170, doi. 10.1002/hon.2823

By:

King, Liam D.;
Sia, Hanlon;
Anoopkumar‐Dukie, Shailendra

Publication type:

Article

Molecular interaction of 4-amino-N'-(benzoyloxy)-N-(2,4-dimethylphenyl)-1,2,5-oxadiazole-3-carboximidamide with the methotrexate binding site of human DHFR, and its implication in rheumatoid arthritis.

Published in:

Tropical Journal of Pharmaceutical Research, 2020, v. 19, n. 5, p. 1045, doi. 10.4314/tjpr.v19i5.20

By:

Shakil, Shazi;
Abuzenadah, Adel M.;
Attar, Suzan M.;
Fathaldin, Omar;
Al-Raddadi, Rajaa;
Sulaiman, Mansour I.

Publication type:

Article

Methotrexate and oral ulceration.

Published in:

British Dental Journal, 2005, v. 198, n. 2, p. 83, doi. 10.1038/sj.bdj.4811972

By:

Deeming, G.M.J.;
Collingwood, J.;
Pemberton, M.N.

Publication type:

Article

Interaction Between Low-Dose Methotrexate and Nonsteroidal Anti-inflammatory Drugs, Penicillins, and Proton Pump Inhibitors.

Published in:

2017

By:

Hall, Jill J.;
Bolina, Monika;
Chatterley, Trish;
Jamali, Fakhreddin

Publication type:

journal article

Potential drug-drug interactions between anti-cancer agents and community pharmacy dispensed drugs.

Published in:

Pharmacy World & Science, 2010, v. 32, n. 5, p. 575, doi. 10.1007/s11096-010-9410-0

By:

Voll, Marsha;
Yap, Kim;
Terpstra, Wim;
Crul, Mirjam

Publication type:

Article

Interaction between methotrexate and omeprazole in an adolescent with leukemia: a case report.

Published in:

Pharmacy World & Science, 2008, v. 30, n. 4, p. 316, doi. 10.1007/s11096-008-9204-9

By:

Tiene Bauters;
Joris Verlooy;
Hugo Robays;
Geneviéve Laureys

Publication type:

Article

<em>Pneumocystis carinii</em> pneumonia following methotrexate.

Published in:

1990

By:

Carmichael, A. J.;
Ryatt, K. S.

Publication type:

Letter

Methotrexate Cutaneous Ulceration: A Systematic Review of Cases.

Published in:

American Journal of Clinical Dermatology, 2022, v. 23, n. 4, p. 449, doi. 10.1007/s40257-022-00692-1

By:

Berna, Ronald;
Rosenbach, Misha;
Margolis, David J.;
Mitra, Nandita;
Baumrin, Emily

Publication type:

Article

Methotrexate: interactions.

Published in:: WHO Drug Information, 2002, v. 16, n. 1, p. 29
Publication type:: Article

Synergistic Effects of BTK Inhibitor HM71224 and Methotrexate in a Collagen-induced Arthritis Rat Model.

Published in:

In Vivo, 2021, v. 35, n. 6, p. 3245, doi. 10.21873/invivo.12619

By:

KYUNG JIN CHOI;
YU-YON KIM;
SUN YOUNG JANG;
YOUNG GIL AHN;
KWEE HYUN SUH;
YOUNG HOON KIM;
HYUNG SIK KIM

Publication type:

Article

Effect of ceftriaxone and cefepime on high-dose methotrexate clearance.

Published in:

Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 6, p. 801, doi. 10.1177/1078155215608524

By:

Tran, Hieu X.;
Herrington, Jon D.

Publication type:

Article

Discovering therapeutic possibilities for polycystic ovary syndrome by targeting XIST and its associated ceRNA network through the analysis of transcriptome data.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-56524-1

By:

Berenji, Elahe;
Valipour Motlagh, Ali;
Fathi, Marziyeh;
Esmaeili, Maryam;
Izadi, Tayebeh;
Rezvanian, Parsa;
Zanjirband, Maryam;
Safaeinejad, Zahra;
Nasr-Esfahani, Mohammad Hossein

Publication type:

Article

The management of psoriasis through diet.

Published in:

Psoriasis: Targets & Therapy, 2012, v. 2, p. 45, doi. 10.2147/ptt.s24755

By:

Duarte, Gleison;
Barbosa, Luan Oliveira;
Rosa, Maria Elisa A.

Publication type:

Article

Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor.

Published in:

2000

By:

Davies, N M;
McLachlan, A J;
Day, R O;
Williams, K M

Publication type:

journal article

P54 Pneumocystis jirovecii prophylaxis in patients on rituximab.

Published in:

Rheumatology, 2019, v. 58, p. N.PAG, doi. 10.1093/rheumatology/kez416.021

By:

Warrier1, Kishore;
Salvesani, Catherine;
Deepak, Samundeeswari

Publication type:

Article